Skip to main content

Sanna Bastiano's Form 4 filing

Vertex Pharmaceuticals Inc (VRTX) · filed Apr 6, 2023

Accession no.
0001209191-23-023588
Filed
Apr 6, 2023
Trade date
Apr 4, 2023
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions. Open-market sales total $164.9K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sanna BastianoCIK 0001829069Officer (EVP, Cell & Genetic Therapies)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 4, 2023Common StockSSaleDisposed−211$314.22F2,F3−$66,300.4247,591Direct
Apr 4, 2023Common StockSSaleDisposed−94$315.66F2,F4−$29,672.0447,497Direct
Apr 4, 2023Common StockSSaleDisposed−90$316.76F2,F5−$28,508.447,407Direct
Apr 4, 2023Common StockSSaleDisposed−96$317.65F2,F6−$30,494.447,311Direct
Apr 4, 2023Common StockSSaleDisposed−31$318.68−$9,879.0847,280Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Referenced by the price of 4 transactions in Table I.

F3

Open market sales reported on this line occurred at a weighted average price of $314.22 (range $313.72 to $314.70).

Referenced by the price of 1 transaction in Table I.

F4

Open market sales reported on this line occurred at a weighted average price of $315.66 (range $315.08 to $315.96).

Referenced by the price of 1 transaction in Table I.

F5

Open market sales reported on this line occurred at a weighted average price of $316.76 (range $316.41 to $317.20).

Referenced by the price of 1 transaction in Table I.

F6

Open market sales reported on this line occurred at a weighted average price of $317.65 (range $317.49 to $317.74).

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)